NERVAL
NERVAL has been active since 1999 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €486k and a net result of €-16k. Equity is growing by ~2.7% per year across the filed fiscal years. Its solvency ranks better than 86% of 4626 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.3% (very low).
| Equity | €486k |
| Net result | €-16k |
| Better than sector | 86% |
| Active | 26 yrs |
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 89.2% | 48.8% | |
| Net result | €-16k | €45k | |
| Equity | €486k | €529k | |
| Gross operating margin | €2k | €82k | |
| Total assets | €545k | €1.52M |
Figures by fiscal year and ratios
| Fiscal year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Deposit | full schema | full schema | full schema |
| Revenue | - | - | - |
| EBITDA | €-1k | €71k | €105k |
| Net profit | €-16k | €42k | €66k |
| Cash flow | €3k | €57k | €82k |
| Staff costs | - | - | - |
| Income taxes | €3k | €19k | €26k |
| Dividends | - | - | €90k |
| Total assets | €545k | €581k | €628k |
| Equity | €486k | €502k | €459k |
| Debt | €20k | €39k | €125k |
| of which ≤ 1y | €18k | €39k | €125k |
| of which > 1y | - | - | - |
| Working capital | €170k | €205k | €159k |
| Employees (FTE) | - | - | - |
| 2024 | 2023 | 2022 | |
|---|---|---|---|
| Current ratio | 10.40 | 6.31 | 2.27 |
| Quick ratio | 10.40 | 6.31 | 2.27 |
| Working capital ratio | 31.2% | 35.2% | 25.3% |
| Solvency | 89.2% | 86.3% | 73.1% |
| Debt / equity | 0.04 | 0.08 | 0.27 |
| Long-term debt ratio | - | - | - |
| Interest coverage | -6.13 | 153.21 | 78.12 |
| Gross margin | - | - | - |
| Net margin | - | - | - |
| ROA | -3.0% | 7.3% | 10.6% |
| ROE | -3.3% | 8.4% | 14.5% |
| EBITDA margin | - | - | - |
| Days sales outstanding | - | - | - |
| Days payable outstanding | - | - | - |
| Inventory turnover | - | - | - |
| Days inventory (DSI) | - | - | - |
Full annual accounts (25 line items)
| Line item | Code | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Balance sheet, Assets | ||||
| TOTAL ASSETS | 20/58 | €545k | €581k | €628k |
| Fixed assets | 21/28 | €357k | €338k | €344k |
| Tangible fixed assets | 22/27 | €357k | €338k | €344k |
| Financial fixed assets | 28 | €87 | €87 | €87 |
| Current assets | 29/58 | €188k | €243k | €284k |
| Amounts receivable within one year | 40/41 | €23k | €15k | €16k |
| Investments | 50/53 | €150k | €221k | €227k |
| Cash & bank | 54/58 | €9k | €6k | €28k |
| Balance sheet, Equity & liabilities | ||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €545k | €581k | €628k |
| Equity | 10/15 | €486k | €502k | €459k |
| Contributions / capital | 10/11 | €6k | €6k | €6k |
| Reserves | 13 | €486k | €491k | €449k |
| Accumulated profits (losses) | 14 | €-7k | €5k | €5k |
| Provisions & deferred taxes | 16 | €39k | €41k | €44k |
| Amounts payable | 17/49 | €20k | €39k | €125k |
| Amounts payable within one year | 42/48 | €18k | €39k | €125k |
| Trade debts payable within one year | 44 | €4k | €16k | €13k |
| Income statement | ||||
| Gross operating margin | 9900 | €2k | €74k | €108k |
| Operating result | 9901 | €-20k | €56k | €90k |
| Financial income | 75 | €5k | €3k | €2k |
| Financial charges | 65 | €192 | €466 | €1k |
| Result before taxes | 9903 | €-16k | €59k | €90k |
| Income taxes | 67/77 | €3k | €19k | €26k |
| Net result for the period | 9904 | €-16k | €42k | €66k |
| Result to be appropriated | 9905 | €-12k | €47k | €71k |
| NACE primary | Business and other management consultancy(70200) |
| Legal form | Private limited company(610) |
| Incorporation | 03-12-1999 |
| Status | Active |
| Postal code | 1200 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21674C0132/00W003 | Brussels | 263 m² | 1 · 94 m² | 8.8 m · 2 fl. |
We know of 5 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
05-07-2023 Transaction in capital or shares
Technical details
{
"events": [
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"_demoted_from": "capital_decrease",
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "suppress"
}
],
"notary": {
"name": "Etienne CARLIER",
"firm_city": null,
"firm_name": null,
"office_city": "P\u00E9ruwelz",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-07-05",
"filing_date": "2023-06-27",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2023-05-26",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0468.009.855",
"name_full": "NERVAL",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 Responsabilit\u00E9 Limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Virginie Louvois",
"org_rep_person_name": null,
"person_role_at_subject": "g\u00E9rant"
},
"co_filed_documents": [
"exp\u00E9dition contenant les statuts mis \u00E0 jour"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Virginie Louvois",
"role": "g\u00E9rant_statutaire",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Romain Carlier",
"role": "simple_associ\u00E9",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "C\u00E9dric Carlier",
"role": "simple_associ\u00E9",
"n_shares": null,
"share_class": null
}
],
"share_classes_after": []
}| Legal nameNL | NERVAL |